Sure thing only the FDA green lighting the SequestOx path to approval says this has little to do with hope at this point. Nasrat has already conducted in house BE studies.
Nasrat already filed generic Percocet and Norco - he isn't having trouble understanding anything.
Intrinsic value about to come in line with the market value in the next 12-18 months.
Elite filed its generic Percocet in August 2016 - May just may be an interesting month for Elite.
Market Data 
Markets 
AI
